Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06186063Not ApplicableRecruiting

The Role of Amylin in Bone Metabolism

Role: lead

NCT04836273Phase 2Completed

Treatment of Post-bariatric Hypoglycaemia

Role: lead

NCT03955575Phase 4Completed

Treatment of Bile Acid Malabsorption With Liraglutide

Role: lead

NCT03017352Phase 2Completed

Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases

Role: lead

NCT02360878Completed

The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones

Role: lead

NCT03093298Not ApplicableCompleted

The Endocrine Secretome After Gastric Bypass Surgery

Role: lead

NCT01656057Not ApplicableCompleted

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Role: lead

All 7 trials loaded